高级检索
当前位置: 首页 > 详情页

External limiting membrane defects in age-related macular degeneration. The Beijing Eye Study

文献详情

资源类型:
Pubmed体系:
机构: [1]Rothschild Foundation Hospital, Institut Français de Myopie, Paris, France. [2]Singapore National Eye Center, Singapore Eye Research Institute, Singapore City, Singapore. [3]Privatpraxis Prof Jonas Und Dr. Panda-Jonas, Heidelberg, Germany. [4]Beijing Visual Science and Translational Eye Research Institute (BERI), Beijing Tsinghua Changgung Hospital, Tsinghua Medicine, Tsinghua University, Beijing, China. [5]L V Prasad Eye Institute, Hyderabad, Telangana, India. [6]Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China. [7]New York Eye and Ear Infirmary of Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York, USA. [8]Department of Ophthalmology, University of Heidelberg, Heidelberg, Germany. [9]Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China. [10]Department of Ophthalmology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.
出处:
ISSN:

关键词: age-related macular degeneration Beijing Eye Study drusen external limiting membrane defect hyperreflective intraretinal foci localized interdigitation zone thinning retinal photoreceptors retinal pigment epithelium

摘要:
To assess the prevalence and associations of external limiting membrane (ELM) defects on optical coherence tomographic (OCT) images in a general population, affected by age-related macular degeneration (AMD) or free of any retinal disease.Using OCT images, we assessed the ELM defect presence in participants of the population-based Beijing Eye Study.The study population consisted of 712 (44.2%) eyes with early AMD, 295 (18.3%) eyes with intermediate AMD, 12 (0.7%) eyes with geographic atrophy and 592 (36.7%) eyes without signs of AMD. ELM defect prevalence increased from 6/592 (1.0%; 95% CI: 0.0, 2.0) in the normal group to 57/712 (8.0%; 95% CI: 6.0, 10.0), 117/295 (39.7%; 95% CI: 34.2, 45.2) and 11/12 (91.7%; 95% CI: 73.7, 100) in the group with early AMD stage, intermediate AMD and late AMD stage, respectively. Higher ELM defect prevalence was spatially associated with higher prevalence of ellipsoid zone (EZ) defects (OR: 929; 95% CI: 291-2964; p < 0.001). In multivariable analysis, higher ELM defect prevalence correlated with higher AMD stage (OR: 2.22; 95% CI: 1.33, 3.71; p = 0.002), higher prevalence of intraretinal hyperreflective foci (iHRFs) superior to the EZ/ELM (OR: 29.7; 95% CI: 8.69-102; p < 0.001), lower prevalence of iHRFs beneath the EZ/ELM (OR: 0.11; 95% CI: 0.04, 0.35; p < 0.001) and higher prevalence of localized interdigitation zone thinnings (IZTs) (OR: 5.66; 95% CI: 3.14, 10.2; p < 0.001).The spatial correlation between ELM defects and EZ defects, the associations of both defect types with a higher occurrence of iHRFs superior to the ELM, the association between an absence of ELM defects and a higher prevalence of iHRFs located inferior to the ELM, and the association between a higher ELM defect prevalence and higher IZT prevalence may suggest the ELM/EZ may act as a barrier for RPE cells migrating into the retina.© 2025 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 3 区 医学
小类 | 2 区 眼科学
最新[2025]版:
大类 | 3 区 医学
小类 | 2 区 眼科学
第一作者:
第一作者机构: [1]Rothschild Foundation Hospital, Institut Français de Myopie, Paris, France. [2]Singapore National Eye Center, Singapore Eye Research Institute, Singapore City, Singapore. [3]Privatpraxis Prof Jonas Und Dr. Panda-Jonas, Heidelberg, Germany. [4]Beijing Visual Science and Translational Eye Research Institute (BERI), Beijing Tsinghua Changgung Hospital, Tsinghua Medicine, Tsinghua University, Beijing, China. [5]L V Prasad Eye Institute, Hyderabad, Telangana, India. [6]Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China. [7]New York Eye and Ear Infirmary of Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
通讯作者:
通讯机构: [4]Beijing Visual Science and Translational Eye Research Institute (BERI), Beijing Tsinghua Changgung Hospital, Tsinghua Medicine, Tsinghua University, Beijing, China. [9]Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:28994 今日访问量:0 总访问量:1619 更新日期:2025-10-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)